ACST Acasti Pharma Inc.

1.01
+0.07  (+7%)
Previous Close 0.94
Open 0.96
Price To Book 13.67
Market Cap 78909853
Shares 78,128,567
Volume 821,334
Short Ratio
Av. Daily Volume 378,889

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data due by the end of 2019.
CaPre (TRILOGY trial)
Hypertriglyceridemia